- Design
- Nationwide register-based cohort with weighted cumulative exposure models
- Population
- 3,749 patients with newly diagnosed SLE in Sweden
- Primary outcome
- First organ damage overall and by domain
- Effect
- HR 1.42 (1.31-1.53) per 5 mg/day over the past two years
A nationwide Swedish register study (Arthritis & Rheumatology, 3 October 2026) followed 3,749 patients with newly diagnosed lupus from 2006 to 2022, using pharmacy dispensing records and weighted cumulative exposure models to ask which window of glucocorticoid exposure best explained organ damage.
The risk of first organ damage was best captured by dosing over the past two years: each 5 mg a day was associated with a hazard ratio of 1.42 (95% CI 1.31-1.53). The past year alone captured most of it (HR 1.34). For cardiovascular damage, dosing over the preceding three years contributed.
The point is that steroid harm accumulates and lingers; the current dose understates exposure. That reinforces the target of tapering to the lowest dose, ideally 5 mg a day or less and off where possible, using steroid-sparing therapy early. The data are observational and higher doses also mark more active disease, which itself causes damage, though the models adjusted for confounders.
- Taper glucocorticoids to the lowest effective dose, aiming for 5 mg a day or less
- Start steroid-sparing therapy early rather than holding a moderate maintenance dose
- Count the past two years of steroid exposure when assessing damage risk
- Look harder for cardiovascular risk factors after several years of steroid use
Why it matters
It shows the dose today understates the steroid burden driving damage over the next years.
Don't overread it
Observational - disease activity drives both steroid dose and damage, so not all of the risk is the drug.
The statistics, in plain English
An HR of 1.42 per 5 mg a day means each additional 5 mg was associated with about 42% higher hazard of first damage. Weighted cumulative exposure models weight past doses by time, which is why a two-year window fitted best. Confounding by disease activity is the main caveat.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free